Anitfibrinolytics are frequently used in patients placed on CPB. The two available lysine analogs, ε-aminocaproic acid and tranexamic acid , bind to lysine binding sites on plasminogen and fibrinogen and thereby inhibit plasminogen activator and plasmin release. [More…]
Home / ABA Keyword of the Day / CPB antifibrinolytics
